本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Artiva Biotherapeutics, Inc.

8.60
-0.3100-3.48%
盤後8.600.00000.00%19:30 EDT
成交量:51.70萬
成交額:447.01萬
市值:4.20億
市盈率:-2.68
高:9.03
開:8.89
低:8.49
收:8.91
52周最高:14.53
52周最低:2.22
股本:4,888.58萬
流通股本:1,898.44萬
量比:1.41
換手率:2.72%
股息:- -
股息率:- -
每股收益(TTM):-3.2084
每股收益(LYR):-3.4309
淨資產收益率:-36.58%
總資產收益率:-22.34%
市淨率:1.21
市盈率(LYR):-2.51

資料載入中...

2026/09/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/09/11

重要事件披露

Form 8-K - Current report
2026/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/22

重要事件披露

Form 8-K - Current report
2026/05/19

重要事件披露

Form 8-K - Current report
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/08

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]